Cirrhosis Management Market

Cirrhosis Management Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment; 2017 – 2027

  • Ongoing
  • October 2020
  • REP-GB-5045
  • Format: PDF/PPT/Excel

  • US$5,000
  • US$7,500
  • US$10,000

This Cirrhosis Management market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Cirrhosis Management market.

Cirrhosis causes the liver to shrink and harden which makes it difficult for the blood to flow into the portal vein in the liver .The liver becomes lumpy and hard, and will start to fail. Basically the liver is a hardy organ and has the ability to regenerate damaged cells. Cirrhosis develops in the liver when factors like chronic viral infections and alcohol are present for a long period of time.  When this condition happens, the liver becomes scarred and injured. Scared liver cannot function properly which ultimately results in cirrhosis. The main causes of cirrhosis are excess alcohol consumption, hepatitis B, Hepatitis C and non-alcoholic fatty liver diseases. 

There are mainly two stages of cirrhosis: compensated and decompensated. In compensated cirrhosis, there are no signs of symptoms which means there is a still presence of healthy liver cells that can meet the body needs. Whereas, decompensated cirrhosis causes symptoms such as fluid will build up in the belly (ascites), toxins will build up in the blood causing confusion, occurrence of gallstones, etc. Chances of these problems can be reduced by keeping a healthy weight, eating a low fat diet, not smoking, sticking to the treatments, not drinking. Treatments like medications, regular doctor visits and lifestyle changes can sometimes prevent or delay the further damaging of the liver.  According to the National Institute of Health (NIH), cirrhosis is the 12th leading cause of death due to the diseases in the United States. Also it is estimated that cirrhosis occurs in 2 inpiduals per 100,000 inpiduals. Cirrhosis is more common in men than women.

  • Identify Key Market Forces and their Long-Term Forecast
  • Sneak Peek into Key Forecast Factors and thier Impact

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Cirrhosis Management Market: Drivers and Restraints

The appropriate method for cirrhosis management is of major importance. Thus it is expected to be the prime factor driving growth of global cirrhosis management.  Increasing prevalence of disease such as non-alcoholic fatty liver diseases is fueling the global cirrhosis management market growth. Moreover, the growing geriatric population has also lead to the significant addition in the global cirrhosis management market. However the lack of low treatment rate due to absence of signs and symptoms of cirrhosis are limiting the growth of global cirrhosis management market.   

Cirrhosis Management Market: Overview

Based on the treatment type, the global cirrhosis management market is segmented into treating cirrhosis causes, symptomatic treatment, treatment to avoid complications and liver transplantation. Based on disease indication, the global cirrhosis management market is segmented into alcoholic liver cirrhosis and non-alcoholic liver cirrhosis. Based on end user, the global cirrhosis management market is segmented into hospitals, ambulatory surgical centers, research institutes, dialysis centers, clinics and others.

Cirrhosis Management Market: Regional Outlook

Geographically, global cirrhosis management market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global cirrhosis management market over the forecast period due to high prevalence of liver cirrhosis diseases. Western Europe is expected to be the second largest market for cirrhosis management.

Cirrhosis Management Market: Key Players 

Some of the players identified in global cirrhosis management market include B. Braun Medical Inc., Alliancells Bioscience Corporation Limited, Conatus Pharmaceuticals Inc., Stempeutics Research Pvt Ltd, Merck Sharp & Dohme Corp., Epic Research & Diagnostics, Inc., Theravance Biopharma R&D, Inc., NovaShunt AG among others

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Cirrhosis Management Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Cirrhosis Management Market: Segmentation

The global cirrhosis management market is segmented on the basis of treatment, disease indication, end user and by geography:

Based on treatment

  • Treating cirrhosis causes
  • Antiviral medications for Hepatitis B & C
  • Corticosteroids
  • Symptomatic Treatment
  • Analgesics
  • Treatment of Portal hypertension (beta blockers. NItrates)
  • Treatment of edema and ascites (diuretics, antibiotics)
  • Treatment to avoid complications
  • Banding procedures/Band Ligation of Varics
  • Dialysis
  • Treatment of Osteoporosis
  • Vaccination for Flu and other
  • Liver Transplantation

Based on Disease Indication

  • Alcoholic Liver Cirrhosis
  • Non-alcoholic Liver Cirrhosis

Based on End User/Service Providers

  • Hospitals
  • Ambulatory Surgical Centers
  • Research Institutes
  • Dialysis Centers
  • Clinics
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Cirrhosis Management Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Cirrhosis Management Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology